Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FYPDQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,086
Award facts
- Contract value 100% obligated
- $5,085.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,085.83 to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order represents a non-competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Otezla is a prescription medication used to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis, supporting the Defense Health Agency and military healthcare systems' pharmaceutical supply requirements.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is registered in the System for Award Management and has demonstrated consistent capability in meeting federal procurement requirements through competitive awards across the Defense Logistics Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FYPDQ?
SPE2DB25FYPDQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FYPDQ worth?
The government has obligated $5,086 on SPE2DB25FYPDQ.
Is contract SPE2DB25FYPDQ an order under another contract?
Yes. SPE2DB25FYPDQ is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYPDQ competed?
The extent of competition for SPE2DB25FYPDQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award